Home / Health / Actor Urges Action on Prostate Cancer
Actor Urges Action on Prostate Cancer
29 Nov
Summary
- Prostate cancer screening PSA is a vital tool, actor states.
- Charity expresses disappointment over insufficient evidence for screening.
- Black men are woefully underrepresented in vital research studies.
- Trial seeks safest, most accurate, and cost-effective screening methods.
An actor, currently undergoing regular check-ups after a prostate cancer diagnosis, is advocating for men, especially those in the black community, to actively seek screening. He stresses the importance of the Prostate-Specific Antigen (PSA) test as a critical weapon against the disease, highlighting that symptoms and pain may only appear when the cancer has already advanced.
Prostate Cancer UK shared their significant disappointment regarding the current limitations in screening evidence, particularly noting the underrepresentation of black men in research. The charity is actively supporting the Transform trial, a research initiative aimed at identifying the most effective, safe, and economical methods for screening men for prostate cancer.
This trial specifically aims to recruit men aged 50-74, with a lowered age threshold of 45 for black men. The actor implored potential participants to engage with the Transform program, emphasizing that early detection is crucial. He also appealed to general practitioners not to dismiss men who request a PSA test, regardless of their symptom status.
